SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : USS - United States Surgical Corporation

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Logain Ablar who wrote ()10/17/1997 11:40:00 AM
From: Logain Ablar   of 30
 
Merrill Lynch initiates coverage today. Looks like some of the pieces are starting to fall into place.

NEW YORK -(Dow Jones)- Merrill Lynch & Co. reinstated coverage of U.S. Surgical Corp. (USS) and Becton Dickinson & Co. (BDX) with a near and long-term "accumulate" rating under a new analyst, Vivian Wohl.

A Merrill spokesman also said Guidant Corp. (GDT) was reinstated with a near and long-term "buy" rating, and that Boston Scientific Corp. (BSX) was reinstated at near-term "neutral" and long-term "buy."

St. Jude Medical Inc. (STJ) also was reinstated with a near-term "neutral" and long-term "accumulate."

Copyright (c) 1997 Dow Jones & Company, Inc.

All Rights Reserved.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext